Severe vivax malaria: Newly recognised or rediscovered?

PLoS Medicine

Volumn 5, Issue 6, 2008, Pages 0875-0877

  Rogerson, Stephen J ^a   Carter, Richard ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; BRAIN MALARIA; COMORBIDITY; DISEASE SEVERITY; DISEASE TRANSMISSION; HUMAN; MALARIA; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RELAPSE; RESPIRATORY DISTRESS; SYMPTOMATOLOGY; ADULT; ANIMAL; INFANT; NOTE; PHYSIOLOGY; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; PREVENTIVE MEDICINE; PROGNOSIS; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME;

ANTIMALARIAL AGENT;

ADULT; ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; HUMANS; INFANT; MALARIA, VIVAX; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREVENTIVE MEDICINE; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 46349109459     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050136     Document Type: Article

References (21)

1. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E. et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Med 5: e128, doi:10.1371/journal.pmed.0050128
2. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, et al. (2008) Plasmodium vivax and mixed Infections are associated with severe malaria in children: A prospective cohort study from Papua New Guinea. FLoS Med 5: e127. doi: 10.1371/journal.pmed.0050127
3. Bejon P, Berkley JA. Mwangi T, Ogada E, Mwangi I, et al. (2007) Defining childhood severe falciparum malaria for Intervention studies. PLoS Med 4: c251. doi:10.1371/journal.pmed.0040251
4. Mayxay M, Pukrittayakamee S, Newton PN, White NJ (2004) Mixed-species malaria infections in humans. Trends Parasitol 20: 233-240.
5. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, et al. (2007) Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua. Indonesia: An open-label randomised comparison. Lancet 369: 757-765.
6. Genton B, al-Yaman F, Mgone CS, Alexander N, Paniu MM, et al. (1995) Ovalocytosis and cerebral malaria. Nature 378: 564-565.
7. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, et al. (2007) Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions In northeastern Indonesian Papua. Am J Trop Med Hyg 77: 984-991.
8. Allen SJ, O'Donncll A, Alexander ND, Clegg JB (1996) Severe malaria in children in Papua New Guinea. QJ Med 89: 779-788.
9. Marsh K, Forster D, Waruiru C, Mwangi I, Win Stanley M. et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404,
10. Issifou S, Kendjo F., Missinou MA, Matsiegui PB, Dzeing-Ella A, et al. (2007) Differences in presentation of severe malaria in urban and rural Gabon. Am J Trop Med Hyg 77: 1015-1019.
11. Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, et al. (2005) Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria JAMA 293: 1461-1470.
12. Maitland K, Williams TN, Newbold CI (1997) Plasmodium vivax and P. falciparum: Biological interactions and the possibility of cross-species immunity, Parasitol Today 13: 227-231.
13. Gunawardena DM, Carter R, Mendis KN (1994) Patterns of acquired anti-malarial immunity in Sri Lanka. Mem Inst Oswaldo Cruz 89: 61-63.
14. Dobson MJ (1994) Malaria in England: A geographical and historical perspective. Parassitologia 36: 35-60.
15. Sinton JA (1935-6) What malaria costs India, nationally, socially and economically. Rec Mal Survey India 5: 223-264, 413-489; 6: 292-169.
16. Mendis K, Sina BJ, Marchesini P, Carter R (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106.
17. Feng X, Carlton JM Joy DA, Mu J Furuya T, et al (2003) Single-nucleotide polymorphisms and genome diversity in Plasmodium vivax. Proc Natl Acad Sci U S A 100: 8502-8507.
18. Singh SK. Hora R, Belrhali H. Chitnis CE. Sharma A (2006) Structural basis for Duffy recognition by the malaria parasite Duflyhinding-like domain. Nature 439: 741-744.
19. Grimherg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, et al. (2007) Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4: e337. doi: 10. 1371/journal.pmed.0040337
20. Malkin KM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, et al. (2005) Phase 1 vaccine trial of Pvs25H: A transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 23: 3131-3138.
21. Panlchakol T, SattabongkotJ. Cholivanich. K, Sirichaisinthop J, Cui L, et al. (2007) Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol 37: 1551-1557.